Literature DB >> 7282395

Cerebral circulation in acute arterial hypertension--protective effects of sympathetic nervous activity.

M Beausang-Linder, A Bill.   

Abstract

The cervical sympathetic chain was stimulated electrically at 6 or 3 Hz on one side in anesthetized cats. Acute arterial hypertension was induced by ligation of the aorta. Evans blue was given as tracer for protein leakage. The regional blood flow in the brain was determined by using labelled microspheres. At high blood pressures there was a multifocal breakdown of the blood-brain barrier. The regions with breakdown had 10-20 times the normal flow rates. With a maintained hypertension regions which were overperfused at 5 min were still overperfused at 10 min, but there was little addition of new overperfused areas. Normalization of the pressure resulted in almost twice the normal flow rates in previously overperfused regions. The breakdown of the blood-brain barrier was restricted to the non-stimulated side, or more marked on that side. The protective effect of the sympathetic stimulation lasted more than 10 min. The results indicate that acute arterial hypertension tends to cause forced and long-lasting vasodilation in some areas in the brain but regions which are resistant to the acute rise have an increase in the vascular tone. Sympathetic activity helps in developing this tone. Normalization of the blood pressure results in partial recovery of the vascular tone in previously overperfused regions and normalization in other areas.

Entities:  

Mesh:

Year:  1981        PMID: 7282395     DOI: 10.1111/j.1748-1716.1981.tb06724.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  43 in total

1.  Clinical and radiological features of brainstem variant of hypertensive encephalopathy.

Authors:  Ioannis Karakis; James A Macdonald; Maria Stefanidou; Carlos S Kase
Journal:  J Vasc Interv Neurol       Date:  2009-04

2.  Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia.

Authors:  P S Rangi; W J Partridge; E S Newlands; A D Waldman
Journal:  Neuroradiology       Date:  2005-07-05       Impact factor: 2.804

3.  [Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil].

Authors:  F Paul; O Aktas; F-J Dieste; P Kreitsch; H-P Vogel; F Zipp
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

4.  [Complexities of "reversible posterior leukoencephalopathy syndrome"].

Authors:  S Herberger; J Linn; T Pfefferkorn; B Feddersen; T Göhringer; F Winkler; A Straube; A Danek
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

5.  Fatal familial insomnia (FFI) complicated by posterior reversible encephalopathy syndrome (PRES).

Authors:  T Froböse; H Förstl; A Förschler
Journal:  Clin Neuroradiol       Date:  2013-10-19       Impact factor: 3.649

Review 6.  Dolichoectasia-an evolving arterial disease.

Authors:  Jose Gutierrez; Ralph L Sacco; Clinton B Wright
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

7.  PRES with asymptomatic spinal cord involvement. Is this scenario more common than we know?

Authors:  L C P Marrone; W A Martins; J P F Brunelli; H Fussiger; G F Carvalhal; J R H Filho; R B Soder; M Schuck; F S Viola; A C H Marrone; J C da Costa
Journal:  Spinal Cord Ser Cases       Date:  2016-01-07

Review 8.  Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?

Authors:  Eva V L Roloff; Ana M Tomiak-Baquero; Sergey Kasparov; Julian F R Paton
Journal:  J Physiol       Date:  2016-10-05       Impact factor: 5.182

Review 9.  The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences.

Authors:  Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-16       Impact factor: 6.200

10.  Brain stem hypertensive encephalopathy evaluated by line scan diffusion-weighted imaging.

Authors:  Motonori Nagata; Masayuki Maeda; Hirokazu Tsukahara; Stephan E Maier; Ken Takeda
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.